Table 2.
Baseline | p-value | The last follow-up | p-value | |||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
N | E | P | N | E | P | |||
Mucosal atrophy | ||||||||
Antrum | 1.00 | 1.10 | 1.24 | 0.156 | 1.10 | 1.46 | 1.28 | 0.013 (N vs E) * |
Corpus | 0.80 | 1.06 | 1.15 | 0.015 (N vs E)* | 0.79 | 1.03 | 1.29 | <0.001 (N vs P)* |
0.009 (N vs P)* | 0.029 (E vs P) * | |||||||
Intestinal metaplasia | ||||||||
Antrum | 1.51 | 1.65 | 1.61 | 0.357 | 1.68 | 1.78 | 1.69 | 0.492 |
Corpus | 1.24 | 1.38 | 1.36 | 0.489 | 1.16 | 1.37 | 1.30 | 0.242 |
Data are presented as mean.
Kruskal-Wallis test. Patients with no precancerous lesion were scored as 0; mild, 1; moderate, 2; and marked, 3 based on the updated Sydney system.
N, negative group; E, eradicated group; P, persistent group.
Mann-Whitney U test for each pair of groups.